Remdesivir speeds up COVID-19 recovery

Embargoed until: Publicly released: 2021-03-25 02:00

International

CC-0

US scientists say the drug remdesivir speeds up COVID-19 recovery. They compared the recovery time of 342 COVID-19 patients who had been given remdesivir with around 2,000 COVID-19 patients who had not. Remdesivir was associated with faster clinical improvement, they say. They also found that giving corticosteroids to patients in addition to remdesivir did not speed up recovery, compared with being given remdesivir alone.

Media release

From: JAMA

Remdesivir and Clinical Improvement in Hospitalized Patients With COVID-19

What The Study Did: This comparative effectiveness research study that included a high proportion of non-White individuals assesses whether remdesivir administered alone or with corticosteroids is associated with time to clinical improvement or time to death in patients hospitalized with confirmed COVID-19.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: Johns Hopkins University School of Medicine, USA

Funder: This work was supported by funding from John Hopkins inHealth, the Johns Hopkins Precision Medicine initiative through JH-CROWN, and the coronavirus disease 2019 (COVID-19) Administrative Supplement for the US Departmentof Health and Human Services (HHS) Region 3 Treatment Center from the Office of the Assistant Secretary for Preparedness and Response (to Drs Garibaldi, Robinson, Gupta, and Xu and Mr K.Wang).

Media Contact/s

Contact details are only visible to registered journalists.